Soleno Therapeutics (SLNO) is up 10.6%, or $6.05 to $62.90.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SLNO:
- Video: Lithium Americas jumps amid talks with DOE, General Motors on loan
- Morning Movers: uniQure skyrockets after AMT-130 trial meets primary endpoint
- Soleno jumps 11% to $63.37 after Acadia trial miss
- Wells sees Soleno’s shares trading up at least 20% on Acadia’s failure in PWS
- Positive Market Outlook for Soleno Therapeutics’ Vykat XR in Prader-Willi Syndrome Treatment